
Venture capital · Growth stage · Est. 2025
JSTAR Capital
JSTAR Capital is a healthcare-focused investor that backs medical technology, biopharma and digital health companies, with SPV-based Fund I and a late-stage Fund II.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is JSTAR Capital right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
Rounds JSTAR Capital joined, from press and the firm’s own posts.
Every round JSTAR Capital joined
Round sizes, JSTAR Capital’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company JSTAR Capital backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet JSTAR Capital
Events where JSTAR Capital’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
JSTAR Capital is based in the United States.
In 2025.
2 fund vehicles are on public registers (SEC adviser filings), including JSTAR HORIZON FUND II, LP and JSTAR HORIZON FUND II, LP.
Stages: Late stage. Sectors: Medtech, Health tech, Biotech. From the firm’s own website.
Backs differentiated medical technologies that meet significant unmet clinical needs, led by experienced operators ahead of key inflection points. Favors capital-efficient companies with clear milestones, and helps portfolio companies reach strategics, distribution partners and clinical champions on the way to partnership or exit. From the firm’s own website.
JSTAR Capital lists 7 portfolio companies on its website, including Sonavex, Adhere Plus (PainScript), OsteoCentric, Emblok and Egg Medical.
Firms whose websites list some of the same companies include TVM Capital Life Science.
Know before JSTAR Capital’s next round is announced.
PRO tracks JSTAR Capital’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.